AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bittium Oyj

Board/Management Information Mar 6, 2025

3258_rns_2025-03-06_8a8190da-ec3a-4219-ba13-7669c064019f.pdf

Board/Management Information

Open in Viewer

Opens in native device viewer

Change in Bittium Corporation's Management Group: Niina Huikuri Appointed as Senior Vice President, Medical Business Segment

Bittium Corporation Changes Board/Management/Auditors

Changein BittiumCorporation'sManagementGroup:Niina Huikuri Appointed as Senior Vice President, Medical Business Segment

Bittium Corporation, Stock Exchange Release, March 6, 2025, at 8.15 am (CET+1)

Niina Huikuri (Ms.Econ) has been appointed as Senior Vice President, Medical Business Segment and a member of Bittium Corporation's management group as of May 1, 2025. She will report to the CEO of Bittium Corporation. Laura Kauppinen, the current Senior Vice President, Medical Business Segment and a member of Bittium Corporation's management group has resigned from her position. She will continue in her position until April 30, 2025.

Niina Huikuri has over 20 years of international commercial experience in the medical devices sector. She joins Bittium from her current position as Chief Commercial Officer of Askel Healthcare Ltd. Prior to her current role, she has worked in various management positions e.g. in Optomed and Johnson & Johnson, leading business development, product management as well as sales and marketing of medical sector products and services. She has experience in building international sales channels in the health technology sector, as well as successful commercialization of medical devices in the US.

"I am happy to be able to welcome Niina to Bittium to build international growth in the Medical Business Segment. Niina has a solid track record in commercializing medical devices and in developing businesses in global markets. The Medical business will focus on international sales growth, implementation of customer-centric operating models in the organization, and increasing competitiveness in the upcoming strategy period," says Petri Toljamo, member of the Board of Directors of Bittium Corporation. "On behalf of the entire company, I would like to thank Laura for the implementation of various processes to improve profitability in Bittium group. Under Laura's leadership in Medical Business Segment, the organization's expertise has been significantly strengthened, and operational efficiency has been improved to enable the implementation of a profitable growth strategy."

Oulu, Finland March 6, 2025

Bittium Corporation The Board of Directors

Further Information:

Karoliina Malmi Vice President, Communications & Sustainability

Distribution

NASDAQ Helsinki Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 40-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology and neurophysiology. Net sales in 2024 were EUR 85.2 million and operating profit EUR 8.6 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.